Intralipid alters macrophage membrane fatty acid composition and inhibits complement (C2) synthesis.
D000818:Animals; D002478:Cells, Cultured; D003175:Complement C2 / Q000096:biosynthesis*; D005217:Fat Emulsions, Intravenous / Q000494:pharmacology*; D005227:Fatty Acids / Q000378:metabolism*; D006168:Guinea Pigs; D006801:Humans; D007700:Kinetics; D008055:Lipids / Q000032:analysis; D008264:Macrophages / Q000187:drug effects / Q000378:metabolism*; D008563:Membrane Lipids / Q000378:metabolism*; D009504:Neutrophils / Q000187:drug effects / Q000502:physiology; D010743:Phospholipids / Q000032:analysis; D013025:Glycine max
D003175:Complement C2; D005217:Fat Emulsions, Intravenous; D005227:Fatty Acids; D008055:Lipids; D008563:Membrane Lipids; D010743:Phospholipids